Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial
Article in The Lancet Neurology (December 2023)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Article in The Lancet Neurology (December 2023)
Article in Scientific Reports (October 2023)
Article in Current Opinion in Pharmacology (December 2022)